ONTX
Price:
$0.9953
Market Cap:
$20.90M
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with PD-1 inhibitor, which is in Phase I/IIa for the treatment of progressive K-Ras mutated non-small cell lung cancer. The company develops a Phase Ib/II ISS with rigosertib monotherapy in patients with advanced squamous cell carcinoma associated with rec...[Read more]
Industry
Biotechnology
IPO Date
2013-07-25
Stock Exchange
NASDAQ
Ticker
ONTX
According to Onconova Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.04. This represents a change of -2.08% compared to the average of -1.06 of the last 4 quarters.
The mean historical PE Ratio of Onconova Therapeutics, Inc. over the last ten years is -1.15. The current -1.04 PE Ratio has changed 8.93% with respect to the historical average. Over the past ten years (40 quarters), ONTX's PE Ratio was at its highest in in the December 2015 quarter at 1.70. The PE Ratio was at its lowest in in the March 2021 quarter at -11.62.
Average
-1.15
Median
-0.78
Minimum
-3.25
Maximum
-0.25
Discovering the peaks and valleys of Onconova Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.18%
Maximum Annual PE Ratio = -0.25
Minimum Annual Increase = -72.62%
Minimum Annual PE Ratio = -3.25
Year | PE Ratio | Change |
---|---|---|
2023 | -0.83 | 11.22% |
2022 | -0.74 | -72.62% |
2021 | -2.71 | -16.60% |
2020 | -3.25 | 1.18% |
2019 | -0.25 | -57.13% |
2018 | -0.59 | 5.83% |
2017 | -0.56 | 9.68% |
2016 | -0.51 | -43.88% |
2015 | -0.91 | -18.62% |
2014 | -1.12 | -42.47% |
The current PE Ratio of Onconova Therapeutics, Inc. (ONTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.43
5-year avg
-1.56
10-year avg
-1.15
Onconova Therapeutics, Inc.’s PE Ratio is less than Jaguar Health, Inc. (-0.07), less than iBio, Inc. (-0.29), less than GeoVax Labs, Inc. (-0.32), greater than Ocugen, Inc. (-5.77), less than Tonix Pharmaceuticals Holding Corp. (-0.00), less than Sonnet BioTherapeutics Holdings, Inc. (-0.55), less than Palisade Bio, Inc. (-0.31), less than Adial Pharmaceuticals, Inc. (-0.34), less than Diffusion Pharmaceuticals Inc. (-0.00), less than Aeterna Zentaris Inc. (-0.10), less than Pulmatrix, Inc. (-0.67), less than Catalyst Biosciences, Inc. (-0.44), less than Bio-Path Holdings, Inc. (-0.14), less than Moleculin Biotech, Inc. (-0.24), greater than Vaxart, Inc. (-2.16), less than VBI Vaccines Inc. (-0.02),
Company | PE Ratio | Market cap |
---|---|---|
-0.07 | $10.26M | |
-0.29 | $15.35M | |
-0.32 | $28.68M | |
-5.77 | $328.16M | |
-0.00 | $3.14M | |
-0.55 | $4.53M | |
-0.31 | $4.25M | |
-0.34 | $6.40M | |
-0.00 | $8.98M | |
-0.10 | $17.51M | |
-0.67 | $7.30M | |
-0.44 | $19.42M | |
-0.14 | $2.51M | |
-0.24 | $6.83M | |
-2.16 | $201.33M | |
-0.02 | $1.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Onconova Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Onconova Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Onconova Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Onconova Therapeutics, Inc. (ONTX)?
What is the highest PE Ratio for Onconova Therapeutics, Inc. (ONTX)?
What is the 3-year average PE Ratio for Onconova Therapeutics, Inc. (ONTX)?
What is the 5-year average PE Ratio for Onconova Therapeutics, Inc. (ONTX)?
How does the current PE Ratio for Onconova Therapeutics, Inc. (ONTX) compare to its historical average?